Erratum: Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity (Proceedings of the National Academy of Sciences of the United States of America (2013) 110 (7458-7463) DOI:10.1073/pnas.1222706110);Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 18, 2013, Pages 7458-7463

  Imperi, Francesco ^a   Massai, Francesco ^b   Facchini, Marcella ^c   Frangipani, Emanuela ^b   Visaggio, Daniela ^a,b   Leoni, Livia ^b   Bragonzi, Alessandra ^c   Visca, Paolo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Antivirulence drug; Cystic fibrosis; Drug repositioning; Iron uptake; Selective optimization of side activities (SOSA) approach

Indexed keywords

EXOTOXIN; EXOTOXIN A; FLUCYTOSINE; PROTEINASE; PRPL PROTEASE; PVDS PROTEIN; PYOVERDINE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG SCREENING; DRUG TARGETING; IN VITRO STUDY; IN VIVO STUDY; LUNG INFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RECOMMENDED DRUG DOSE; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 84876936620     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1316459110     Document Type: Erratum

References (38)

1. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ (2008) The biology and future prospects of antivirulence therapies. Nat Rev Microbiol 6(1):17-27. (Pubitemid 350286217)
2. Rasko DA, Sperandio V (2010) Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9(2):117-128.
3. Wermuth CG (2006) Selective optimization of side activities: The SOSA approach. Drug Discov Today 11(3-4):160-164.
4. Driscoll JA, Brody SL, Kollef MH (2007) The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67(3):351-368. (Pubitemid 46425550)
5. Page MG, Heim J (2009) Prospects for the next anti-Pseudomonas drug. Curr Opin Pharmacol 9(5):558-565.
6. Kipnis E, Sawa T, Wiener-Kronish J (2006) Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med Mal Infect 36(2):78-91. (Pubitemid 43294628)
7. Lee DG, et al. (2006) Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol 7(10):R90.
8. Banin E, Vasil ML, Greenberg EP (2005) Iron and Pseudomonas aeruginosa biofilm formation. Proc Natl Acad Sci USA 102(31):11076-11081. (Pubitemid 41105995)
9. Visca P, Imperi F, Lamont IL (2007) Pyoverdine siderophores: From biogenesis to biosignificance. Trends Microbiol 15(1):22-30. (Pubitemid 46038729)
10. Lamont IL, Beare PA, Ochsner U, Vasil AI, Vasil ML (2002) Siderophore-mediated signaling regulates virulence factor production in Pseudomonasaeruginosa. Proc Natl Acad Sci USA 99(10):7072-7077. (Pubitemid 34526257)
11. Nairz M, Schroll A, Sonnweber T, Weiss G (2010) The struggle for iron - a metal at the host-pathogen interface. Cell Microbiol 12(12):1691-1702.
12. Ochsner UA, Wilderman PJ, Vasil AI, Vasil ML (2002) GeneChip expression analysis of the iron starvation response in Pseudomonas aeruginosa: Identification of novel pyoverdine biosynthesis genes. Mol Microbiol 45(5):1277-1287. (Pubitemid 35015352)
13. Drake EJ, Gulick AM (2011) Structural characterization and high-throughput screening of inhibitors of PvdQ, an NTN hydrolase involved in pyoverdine synthesis. ACS Chem Biol 6(11):1277-1286.
14. Bodilis J, et al. (2009) Distribution and evolution of ferripyoverdine receptors in Pseudomonas aeruginosa. Environ Microbiol 11(8):2123-2135.
15. Bragonzi A, et al. (2009) Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 180(2):138-145.
16. Tiburzi F, Imperi F, Visca P (2008) Intracellular levels and activity of PvdS, the major iron starvation sigma factor of Pseudomonas aeruginosa . Mol Microbiol 67(1):213-227. (Pubitemid 350231147)
17. Michel L, González N, Jagdeep S, Nguyen-Ngoc T, Reimmann C (2005) PchR-box recognition by the AraC-type regulator PchR of Pseudomonas aeruginosa requires the siderophore pyochelin as an effector. Mol Microbiol 58(2):495-509. (Pubitemid 41476164)
18. Edlind TD, Katiyar SK (2010) Mutational analysis of flucytosine resistance in Candida glabrata. Antimicrob Agents Chemother 54(11):4733-4738.
19. Pan X, et al. (2011) Development of 5-Fluorouracil derivatives as anticancer agents. Curr Med Chem 18(29):4538-4556.
20. Danielsen S, Kilstrup M, Barilla K, Jochimsen B, Neuhard J (1992) Characterization of the Escherichia coli codBA operon encoding cytosine permease and cytosine deaminase. Mol Microbiol 6(10):1335-1344.
21. Vermes A, Guchelaar HJ, Dankert J (2000) Flucytosine: A review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 46(2):171-179. (Pubitemid 30639285)
22. Yamada H, Kotaki H, Takahashi T (2003) Recommendations for the treatment of fungal pneumonias. Expert Opin Pharmacother 4(8):1241-1258. (Pubitemid 36949674)
23. Stamm AM, et al. (1987) Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am J Med 83(2):236-242.
24. Jenner BM, Landau LI, Phelan PD (1979) Pulmonary candidiasis in cystic fibrosis. Arch Dis Child 54(7):555-556. (Pubitemid 9212613)
25. Radike K, Kunzmann S, Abele-Horn M, Beer M, Hebestreit H (2011) Osteoarticular infection by Candida albicans in an infant with cystic fibrosis. J Med Microbiol 60(Pt 10):1542-1545.
26. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Lab Press, Cold Spring Harbor, NY), 2nd Ed.
27. Ohman DE, Sadoff JC, Iglewski BH (1980) Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: Isolation and characterization. Infect Immun 28(3):899-908. (Pubitemid 10122521)
28. Becher A, Schweizer HP (2000) Integration-proficient Pseudomonas aeruginosa vectors for isolation of single-copy chromosomal lacZ and lux gene fusions. Biotechniques 29(5):948-950, 952.
29. Cunliffe HE, Merriman TR, Lamont IL (1995) Cloning and characterization of pvdS, a gene required for pyoverdine synthesis in Pseudomonas aeruginosa: PvdS is probably an alternative sigma factor. J Bacteriol 177(10):2744-2750.
30. Massai F, et al. (2011) A multitask biosensor for micro-volumetric detection of N-3-oxo-dodecanoyl-homoserine lactone quorum sensing signal. Biosens Bioelectron 26(8):3444-3449.
31. Cipollone R, et al. (2007) Involvement of Pseudomonas aeruginosa rhodanese in protection from cyanide toxicity. Appl Environ Microbiol 73(2):390-398. (Pubitemid 46147567)
32. Rampioni G, et al. (2010) Transcriptomic analysis reveals a global alkyl-quinolone-independent regulatory role for PqsE in facilitating the environmental adaptation of Pseudomonas aeruginosa to plant and animal hosts. Environ Microbiol 12(6):1659-1673.
33. Imperi F, Tiburzi F, Visca P (2009) Molecular basis of pyoverdine siderophore recycling in Pseudomonas aeruginosa. Proc Natl Acad Sci USA 106(48):20440-20445.
34. Imperi F, Tiburzi F, Fimia GM, Visca P (2010) Transcriptional control of the pvdS iron starvation sigma factor gene by the master regulator of sulfur metabolism CysB in Pseudomonas aeruginosa. Environ Microbiol 12(6):1630-1642.
35. Miller JH (1972) Experiments in Molecular Genetics (Cold Spring Harbor Lab Press, Plainview, NY).
36. Zhang S, et al. (2005) Comparative signature-tagged mutagenesis identifies Pseudomonas factors conferring resistance to the pulmonary collectin SP-A. PLoS Pathog 1(3):259-268.
37. Cox CD, Graham R (1979) Isolation of an iron-binding compound from Pseudomonas aeruginosa. J Bacteriol 137(1):357-364. (Pubitemid 9097580)
38. Imperi F, et al. (2008) Membrane-association determinants of the omega-amino acid monooxygenase PvdA, a pyoverdine biosynthetic enzyme from Pseudomonas aeruginosa. Microbiology 154(Pt 9):2804-2813.